QTRX

Quanterix Corporation NASDAQ Listed Dec 7, 2017

Healthcare ·Medical - Devices ·US · quanterix.com

$3.29

After hrs $3.22 -2.04%

Mkt Cap $154.4M

52w Low $2.95 5.8% of range 52w High $8.77

50d MA $4.16 200d MA $5.48

P/E (TTM) -1.4x

EV/EBITDA -4.1x

P/B 0.5x

Debt/Equity 0.1x

ROE -36.2%

P/FCF -3.4x

RSI (14) —

ATR (14) —

Beta 1.32

50d MA $4.16

200d MA $5.48

Avg Volume 779.5K

About

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researc…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 2, 2026	AMC	-0.27	-0.38	-40.7%	6.33	-4.9%	-7.3%	-7.4%	-16.1%	-20.1%	-19.4%	—
Nov 10, 2025	AMC	-0.23	-0.36	-56.5%	5.12	-3.5%	-2.3%	+2.0%	+3.9%	+12.1%	+8.0%	—
Aug 7, 2025	AMC	-0.41	-0.47	-14.6%	5.51	-10.9%	-13.8%	-16.9%	-13.6%	-13.1%	-17.6%	—
May 12, 2025	AMC	-0.69	-0.53	+23.2%	5.73	-0.2%	-19.0%	-25.3%	-21.5%	-16.4%	-15.0%	—
Mar 17, 2025	AMC	-0.27	-0.30	-11.1%	7.28	-8.5%	-1.8%	-1.1%	-0.5%	-0.8%	-1.2%	—
Dec 23, 2024	AMC	-0.24	-0.22	+8.3%	10.65	-0.3%	-1.2%	+3.9%	+3.8%	+2.3%	-0.2%	—
Aug 8, 2024	AMC	-0.27	-0.25	+7.4%	12.82	-13.7%	-14.8%	-12.1%	-13.1%	-12.5%	-11.5%	—
May 7, 2024	AMC	-0.31	-0.26	+16.1%	17.36	-0.1%	-4.9%	-1.4%	-3.9%	-2.9%	-3.1%	—
Feb 29, 2024	AMC	-0.32	-0.33	-3.1%	23.96	-4.3%	+12.7%	+17.2%	+17.7%	+18.0%	+17.1%	—
Nov 6, 2023	AMC	-0.37	-0.21	+43.2%	22.06	+2.1%	+2.2%	+0.1%	-7.2%	-7.1%	-6.2%	—
Aug 7, 2023	AMC	-0.38	-0.16	+57.9%	21.73	+16.9%	+16.9%	+19.0%	+11.3%	+15.3%	+16.8%	—
May 9, 2023	AMC	-0.38	-0.16	+57.9%	17.50	+4.9%	+0.6%	-3.9%	-7.9%	-0.1%	+4.1%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 20	Canaccord Genuity	Maintains	Hold → Hold	—	$3.50	$3.41	-2.6%	-5.7%	-8.0%	-6.9%	-9.7%	-6.3%
Dec 22	Canaccord Genuity	Maintains	Hold → Hold	—	$6.59	$6.75	+2.4%	+3.2%	+0.8%	+0.5%	-2.0%	-3.5%
Aug 11	Canaccord Genuity	Downgrade	Buy → Hold	—	$4.75	$4.57	-3.8%	-3.6%	+0.2%	+0.8%	-4.4%	-3.8%
May 13	Canaccord Genuity	Maintains	Buy → Buy	—	$5.73	$5.72	-0.2%	-19.0%	-25.3%	-21.5%	-16.4%	-15.0%
Apr 30	Leerink Partners	Downgrade	Outperform → Market Perform	—	$6.05	$5.62	-7.1%	-4.8%	-4.6%	-0.5%	-4.0%	-11.6%
Mar 25	Scotiabank	Maintains	Sector Outperform → Sector Outperform	—	$7.19	$7.15	-0.6%	-2.4%	-7.4%	-5.8%	-8.8%	-9.5%
Mar 18	Canaccord Genuity	Maintains	Buy → Buy	—	$7.28	$6.66	-8.5%	-1.8%	-1.1%	-0.5%	-0.8%	-1.2%
Nov 13	TD Cowen	Maintains	Hold → Hold	—	$15.17	$15.15	-0.1%	-18.3%	-21.4%	-24.6%	-26.3%	-27.1%
Aug 12	Scotiabank	Maintains	Sector Outperform → Sector Outperform	—	$10.92	$10.91	-0.1%	+3.2%	+2.0%	+2.7%	+3.9%	+13.6%
Aug 9	TD Cowen	Maintains	Hold → Hold	—	$12.82	$11.07	-13.7%	-14.8%	-12.1%	-13.1%	-12.5%	-11.5%
Jul 9	Goldman Sachs	Maintains	Buy → Buy	—	$12.23	$12.19	-0.3%	+3.4%	+8.6%	+15.1%	+18.5%	+23.3%
Apr 29	Canaccord Genuity	Maintains	Buy → Buy	—	$15.56	$15.64	+0.5%	+0.1%	+3.6%	+6.0%	+8.7%	+9.4%
Mar 4	Scotiabank	Maintains	Sector Outperform → Sector Outperform	—	$27.00	$28.00	+3.7%	+4.0%	+4.5%	+4.7%	+3.9%	-1.7%
Sep 28	Goldman Sachs	Maintains	Buy → Buy	—	$27.39	$27.43	+0.1%	+2.1%	-0.9%	-2.5%	-2.4%	-4.3%
Sep 27	Goldman Sachs	Maintains	Buy → Buy	—	$25.56	$26.51	+3.7%	+7.2%	+9.4%	+6.2%	+4.5%	+4.6%
Sep 25	Canaccord Genuity	Upgrade	Hold → Buy	—	$25.01	$26.06	+4.2%	+3.7%	+2.2%	+9.5%	+11.8%	+8.5%
Aug 9	Goldman Sachs	Maintains	Buy → Buy	—	$25.40	$25.62	+0.9%	+1.8%	-4.8%	-1.4%	-0.1%	+4.8%
May 24	Goldman Sachs	Maintains	Buy → Buy	—	$21.00	$20.96	-0.2%	+0.6%	-1.1%	-1.0%	-5.7%	-6.6%
May 23	Goldman Sachs	Upgrade	Neutral → Buy	—	$19.23	$20.96	+9.0%	+9.2%	+9.8%	+8.0%	+8.1%	+3.0%
Nov 10	Goldman Sachs	Maintains	Neutral → Neutral	—	$9.45	$10.19	+7.8%	+24.0%	+34.2%	+35.9%	+28.6%	+25.0%
Nov 9	SVB Leerink	Maintains	Market Perform → Market Perform	—	$9.33	$10.26	+10.0%	+1.3%	+25.6%	+35.9%	+37.6%	+30.2%
Aug 15	Canaccord Genuity	Downgrade	Buy → Hold	—	$10.46	$10.07	-3.7%	-2.7%	-6.6%	-6.4%	-9.1%	-11.8%
Aug 10	Goldman Sachs	Maintains	Neutral → Neutral	—	$7.46	$7.64	+2.4%	+14.7%	+36.2%	+40.2%	+36.5%	+31.0%
Aug 9	SVB Leerink	Downgrade	Outperform → Market Perform	—	$16.49	$9.96	-39.6%	-54.8%	-48.1%	-38.4%	-36.6%	-38.3%
Aug 9	Cowen & Co.	Downgrade	Outperform → Market Perform	—	$16.49	$9.96	-39.6%	-54.8%	-48.1%	-38.4%	-36.6%	-38.3%
Jul 14	Goldman Sachs	Maintains	Neutral → Neutral	—	$18.30	$18.00	-1.6%	-4.0%	-1.6%	-6.8%	-2.9%	+2.1%
May 11	Goldman Sachs	Maintains	Neutral → Neutral	—	$16.82	$17.03	+1.2%	-8.3%	-6.4%	+11.7%	+6.4%	+10.0%
May 11	SVB Leerink	Maintains	Outperform → Outperform	—	$16.82	$17.03	+1.2%	-8.3%	-6.4%	+11.7%	+6.4%	+10.0%
Apr 13	Goldman Sachs	Maintains	Neutral → Neutral	—	$27.95	$27.49	-1.6%	-2.8%	-7.5%	-10.6%	-9.4%	-11.1%
Mar 2	JP Morgan	Maintains	Overweight → Overweight	—	$31.60	$33.83	+7.1%	+3.5%	-0.3%	-6.0%	-12.5%	-14.4%
Mar 2	Goldman Sachs	Upgrade	Sell → Neutral	—	$31.60	$33.83	+7.1%	+3.5%	-0.3%	-6.0%	-12.5%	-14.4%
Mar 2	SVB Leerink	Maintains	Outperform → Outperform	—	$31.60	$33.83	+7.1%	+3.5%	-0.3%	-6.0%	-12.5%	-14.4%
Aug 5	Canaccord Genuity	Maintains	Buy → Buy	—	$55.14	$54.56	-1.1%	+3.3%	-5.0%	-0.8%	-6.7%	-10.9%
Jun 4	Goldman Sachs	Maintains	Sell → Sell	—	$53.56	$50.88	-5.0%	+1.0%	+11.8%	+18.5%	+15.7%	+25.4%
May 6	SVB Leerink	Maintains	Outperform → Outperform	—	$52.77	$50.26	-4.8%	-0.1%	+6.3%	-11.0%	-6.8%	-10.6%
Mar 3	SVB Leerink	Maintains	Outperform → Outperform	—	$77.10	$84.89	+10.1%	-15.1%	-18.1%	-12.6%	-23.7%	-21.7%
Jan 27	SVB Leerink	Maintains	Outperform → Outperform	—	$66.47	$65.90	-0.9%	-8.5%	-0.6%	-2.6%	+4.5%	+12.3%
Nov 6	SVB Leerink	Maintains	Outperform → Outperform	—	$44.09	$45.58	+3.4%	+12.7%	-2.8%	+2.0%	+13.0%	+10.6%
Oct 19	SVB Leerink	Maintains	Outperform → Outperform	—	$42.34	$44.59	+5.3%	+0.8%	-3.4%	-4.7%	-3.5%	-4.1%
Oct 6	Canaccord Genuity	Maintains	Buy → Buy	—	$35.35	$36.33	+2.8%	+4.4%	+22.7%	+28.1%	+30.6%	+27.2%
Aug 5	SVB Leerink	Maintains	Outperform → Outperform	—	$33.00	$32.89	-0.3%	+6.2%	+5.8%	+0.4%	+0.6%	+1.3%
Oct 10	Canaccord Genuity	Maintains	Buy → Buy	—	$18.37	$18.88	+2.8%	-0.2%	-2.6%	-4.3%	-2.6%	-1.9%
Jan 2	Cowen & Co.	Maintains	Outperform → Outperform	—	$21.47	$21.53	+0.3%	-8.9%	-11.1%	-9.2%	-9.3%	-8.0%
Jan 2	Leerink Swann	Maintains	Outperform → Outperform	—	$21.47	$21.53	+0.3%	-8.9%	-11.1%	-9.2%	-9.3%	-8.0%
Jan 2	JP Morgan	Maintains	Overweight → Overweight	—	$21.47	$21.53	+0.3%	-8.9%	-11.1%	-9.2%	-9.3%	-8.0%
Jan 2	BTIG Research	Maintains	Buy → Buy	—	$21.47	$21.53	+0.3%	-8.9%	-11.1%	-9.2%	-9.3%	-8.0%

Recent Filings

8-K · 2.02 !! High

Quanterix Corporation -- 8-K 2.02: Earnings Results

Quanterix released Q1 2026 earnings results showing financial performance for the quarter ended March 31, 2026, providing investors with updated operational metrics and financial condition updates.

May 6

8-K

Quanterix Corporation -- 8-K Filing

Quanterix reported $122 million in cash and projects reaching cash flow breakeven in 2026, indicating the biomarker detection company is progressing toward financial sustainability without requiring immediate capital raises.

Mar 2

Data updated apr 26, 2026 9:39pm · Source: massive.com